U.S. will pay $1.6 billion to Novavax to develop coronavirus vaccine

The Trump administration has awarded a contract worth $1.6 billion to a Maryland biotechnology company to develop a coronavirus vaccine, the largest bet yet by the federal government on an individual vaccine to combat the pandemic. The deal with Novavax, a publicly traded company based in Gaithersburg, will pay for late-stage clinical trials and secure […]